Integrated physiology and systems biology of PPARα
Tóm tắt
Từ khóa
Tài liệu tham khảo
Issemann, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0
Dreyer, 1992, Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors, Cell, 68, 879, 10.1016/0092-8674(92)90031-7
Chawla, 2001, Nuclear receptors and lipid physiology: opening the X-files, Science, 294, 1866, 10.1126/science.294.5548.1866
Gronemeyer, 1995, Transcription factors 3: nuclear receptors, Protein Profile, 2, 1173
Tugwood, 1992, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene, EMBO Journal, 11, 433, 10.1002/j.1460-2075.1992.tb05072.x
Lefterova, 2008, PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale, Genes & Development, 22, 2941, 10.1101/gad.1709008
DiRenzo, 1997, Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors, Molecular and Cellular Biology, 17, 2166, 10.1128/MCB.17.4.2166
Mukherjee, 1997, Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists, Nature, 386, 407, 10.1038/386407a0
Schulman, 1998, Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function, Molecular and Cellular Biology, 18, 3483, 10.1128/MCB.18.6.3483
Yu, 2007, Transcription coactivators for peroxisome proliferator-activated receptors, Biochimica et Biophysica Acta, 1771, 936, 10.1016/j.bbalip.2007.01.008
Viswakarma, 2010, Coactivators in PPAR-regulated gene expression, PPAR Research, 2010, 10.1155/2010/250126
Venteclef, 2011, Metabolic nuclear receptor signaling and the inflammatory acute phase response, Trends in Endocrinology and Metabolism: TEM, 22, 333, 10.1016/j.tem.2011.04.004
Georgiadi, 2012, Mechanisms of gene regulation by fatty acids, Advances in Nutrition, 3, 127, 10.3945/an.111.001602
Bookout, 2006, Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network, Cell, 126, 789, 10.1016/j.cell.2006.06.049
Escher, 2001, Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding, Endocrinology, 142, 4195, 10.1210/endo.142.10.8458
Georgiadi, 2012, Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart, Physiological Genomics, 44, 352, 10.1152/physiolgenomics.00115.2011
Madrazo, 2008, The PPAR trio: regulators of myocardial energy metabolism in health and disease, Journal of Molecular and Cellular Cardiology, 44, 968, 10.1016/j.yjmcc.2008.03.021
Bunger, 2007, Genome-wide analysis of PPARalpha activation in murine small intestine, Physiological Genomics, 30, 192, 10.1152/physiolgenomics.00198.2006
Cahill, 2006, Fuel metabolism in starvation, Annual Review of Nutrition, 26, 1, 10.1146/annurev.nutr.26.061505.111258
Hashimoto, 2000, Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting, Journal of Biological Chemistry, 275, 28918, 10.1074/jbc.M910350199
Kersten, 1999, Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, Journal of Clinical Investigation, 103, 1489, 10.1172/JCI6223
Leone, 1999, A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders, Proceedings of the National Academy of Sciences of the United States of America, 96, 7473, 10.1073/pnas.96.13.7473
Patsouris, 2004, PPARalpha governs glycerol metabolism, Journal of Clinical Investigation, 114, 94, 10.1172/JCI200420468
Sugden, 2002, Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin, Biochemical Journal, 364, 361, 10.1042/bj20011699
Sanderson, 2010, Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver, Physiological Genomics, 41, 42, 10.1152/physiolgenomics.00127.2009
Makowski, 2009, Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation, FASEB Journal, 23, 586, 10.1096/fj.08-119420
Le May, 2000, Reduced hepatic fatty acid oxidation in fasting PPARalpha null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression, FEBS Letters, 475, 163, 10.1016/S0014-5793(00)01648-3
Atherton, 2009, Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse, Molecular Systems Biology, 5, 259, 10.1038/msb.2009.18
De Souza, 2006, Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice, Nucleic Acids Research, 34, 4486, 10.1093/nar/gkl609
Xu, 2002, Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production, Journal of Biological Chemistry, 277, 50237, 10.1074/jbc.M201208200
Bandsma, 2004, Hepatic de novo synthesis of glucose 6-phosphate is not affected in peroxisome proliferator-activated receptor alpha-deficient mice but is preferentially directed toward hepatic glycogen stores after a short term fast, Journal of Biological Chemistry, 279, 8930, 10.1074/jbc.M310067200
Mandard, 2007, Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors, Cellular and Molecular Life Sciences, 64, 1145, 10.1007/s00018-007-7006-1
Derks, 2008, Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice, Hepatology, 47, 1032, 10.1002/hep.22101
Rakhshandehroo, 2007, Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling, PPAR Research, 2007, 26839, 10.1155/2007/26839
Xu, 2004, Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux, Endocrinology, 145, 1087, 10.1210/en.2003-1173
Knauf, 2006, Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain, Endocrinology, 147, 4067, 10.1210/en.2005-1536
Kersten, 2001, The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism, FASEB Journal, 15, 1971, 10.1096/fj.01-0147com
Ciana, 2007, A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver, Molecular Endocrinology, 21, 388, 10.1210/me.2006-0152
Gottlicher, 1992, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proceedings of the National Academy of Sciences of the United States of America, 89, 4653, 10.1073/pnas.89.10.4653
Chakravarthy, 2005, “New” hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis, Cell Metabolism, 1, 309, 10.1016/j.cmet.2005.04.002
Sanderson, 2009, Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver, Molecular and Cellular Biology, 29, 6257, 10.1128/MCB.00370-09
Lemberger, 1996, Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm, Journal of Biological Chemistry, 271, 1764, 10.1074/jbc.271.3.1764
Gachon, 2011, Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity, Proceedings of the National Academy of Sciences of the United States of America, 108, 4794, 10.1073/pnas.1002862108
Haemmerle, 2011, ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1, Nature Medicine, 17, 1076, 10.1038/nm.2439
Ong, 2011, Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning, Hepatology, 53, 116, 10.1002/hep.24006
Settembre, 2013, TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop, Nature Cell Biology, 15, 647, 10.1038/ncb2718
Forman, 1997, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta, Proceedings of the National Academy of Sciences of the United States of America, 94, 4312, 10.1073/pnas.94.9.4312
Lee, 1995, Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Molecular and Cellular Biology, 15, 3012, 10.1128/MCB.15.6.3012
Duval, 2007, PPARalpha and dyslipidemia, Biochimica et Biophysica Acta, 1771, 961, 10.1016/j.bbalip.2007.05.003
Staels, 2008, Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Nature clinical practice, Cardiovascular Medicine, 5, 542
Peters, 1997, Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643, Carcinogenesis, 18, 2029, 10.1093/carcin/18.11.2029
Gonzalez, 2002, The peroxisome proliferator-activated receptor alpha (PPARalpha): role in hepatocarcinogenesis, Molecular and Cellular Endocrinology, 193, 71, 10.1016/S0303-7207(02)00098-9
Mukherjee, 1998, RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo, Arteriosclerosis Thrombosis and Vascular Biology, 18, 272, 10.1161/01.ATV.18.2.272
Wang, 2006, Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide, Molecular Cancer Therapeutics, 5, 1060, 10.1158/1535-7163.MCT-05-0322
Martin, 2005, Transcriptional modulations by RXR agonists are only partially subordinated to PPARalpha signaling and attest additional, organ-specific, molecular cross-talks, Gene Expression, 12, 177, 10.3727/000000005783992098
Ouamrane, 2003, RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart, British Journal of Pharmacology, 138, 845, 10.1038/sj.bjp.0705113
Cornu-Chagnon, 1995, Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes, Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology, 26, 63, 10.1006/faat.1995.1075
Gray, 1983, Peroxisome proliferation in primary cultures of rat hepatocytes, Toxicology and Applied Pharmacology, 67, 15, 10.1016/0041-008X(83)90240-5
Lake, 1984, The effect of hypolipidaemic agents on peroxisomal beta-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation, Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 14, 269, 10.3109/00498258409151411
Paul, 1979, Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation, Journal of Clinical Investigation, 64, 405, 10.1172/JCI109476
Furuta, 1981, Induction of acyl-CoA dehydrogenases and electron transfer flavoprotein and their roles in fatty acid oxidation in rat liver mitochondria, Journal of Biochemistry, 90, 1751, 10.1093/oxfordjournals.jbchem.a133652
Glatz, 1983, Effect of clofibrate feeding on palmitate and branched-chain 2-oxo acid oxidation in rat liver and muscle, Biochemical Pharmacology, 32, 2489, 10.1016/0006-2952(83)90007-2
Kahonen, 1979, Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver. Dose–response relations, Atherosclerosis, 32, 47, 10.1016/0021-9150(79)90146-1
Kawashima, 1985, Effects of long-term administration of clofibric acid on peroxisomal beta-oxidation, fatty acid-binding protein and cytosolic long-chain acyl-CoA hydrolases in rat liver, Biochemical Pharmacology, 34, 325, 10.1016/0006-2952(85)90039-5
Mannaerts, 1979, Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats, Journal of Biological Chemistry, 254, 4585, 10.1016/S0021-9258(17)30051-0
Mortensen, 1983, Beta-oxidation of C-6-C-10 fatty acids in rat liver homogenates measured by selected ion monitoring: effects of cyanide and clofibrate, Biomedical Mass Spectrometry, 10, 528, 10.1002/bms.1200100908
Pande, 1980, Clofibrate enhancement of mitochondrial carnitine transport system of rat liver and augmentation of liver carnitine and gamma-butyrobetaine hydroxylase activity by thyroxine, Biochimica et Biophysica Acta, 617, 363, 10.1016/0005-2760(80)90002-8
Reddy, 1982, Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs, Human Toxicology, 1, 135, 10.1177/096032718200100205
Bodnar, 1990, Cloning and sequence determination of cDNA encoding a second rat liver peroxisomal 3-ketoacyl-CoA thiolase, Gene, 91, 193, 10.1016/0378-1119(90)90088-9
Ozasa, 1985, Induction of peroxisomal beta-oxidation enzymes in primary cultured rat hepatocytes by clofibric acid, Journal of Biochemistry, 97, 1273, 10.1093/oxfordjournals.jbchem.a135178
Reddy, 1986, Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators, Proceedings of the National Academy of Sciences of the United States of America, 83, 1747, 10.1073/pnas.83.6.1747
Kahonen, 1979, Effect of clofibrate treatment on acylcarnitine oxidation in isolated rat liver mitochondria, Medical Biology, 57, 58
Lazarow, 1976, A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug, Proceedings of the National Academy of Sciences of the United States of America, 73, 2043, 10.1073/pnas.73.6.2043
Osmundsen, 1982, A role for 2,4-enoyl-CoA reductase in mitochondrial beta-oxidation of polyunsaturated fatty acids. Effects of treatment with clofibrate on oxidation of polyunsaturated acylcarnitines by isolated rat liver mitochondria, Biochemical Journal, 208, 749, 10.1042/bj2080749
Veitch, 1988, Effects of riboflavin deficiency and clofibrate treatment on the five acyl-CoA dehydrogenases in rat liver mitochondria, Biochemical Journal, 254, 477, 10.1042/bj2540477
Orton, 1982, The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid, Drug Metabolism and Disposition: the Biological Fate of Chemicals, 10, 110
Sharma, 1988, Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies, Biochemical Pharmacology, 37, 1203, 10.1016/0006-2952(88)90771-X
Sharma, 1989, Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation, European Journal of Biochemistry, 184, 69, 10.1111/j.1432-1033.1989.tb14991.x
Bergseth, 1986, The effect of feeding fish oils, vegetable oils and clofibrate on the ketogenesis from long chain fatty acids in hepatocytes, Lipids, 21, 508, 10.1007/BF02535638
el Kebbaj, 1995, Effect of peroxisomes proliferators and hypolipemic agents on mitochondrial inner membrane linked D-3-hydroxybutyrate dehydrogenase (BDH), Biochemistry and Molecular Biology International, 35, 65
Krueger, 1976, Tumor-associated antigens in human myeloma, Journal of the National Cancer Institute, 56, 711, 10.1093/jnci/56.4.711
Kersten, 2008, Peroxisome proliferator activated receptors and lipoprotein metabolism, PPAR Research, 2008, 132960, 10.1155/2008/132960
Haluzik, 2006, Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels, Endocrinology, 147, 4517, 10.1210/en.2005-1624
Nagasawa, 2006, Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet, European Journal of Pharmacology, 536, 182, 10.1016/j.ejphar.2006.02.028
Chan, 2013, Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased ER stress, Diabetes, 62, 2095, 10.2337/db12-1397
Hwang, 2012, Additive effects of clofibric acid and pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet, FEBS Journal, 279, 1883, 10.1111/j.1742-4658.2012.08569.x
Sasaki, 2011, Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome, European Journal of Pharmacology, 662, 1, 10.1016/j.ejphar.2011.04.051
Tailleux, 2012, Roles of PPARs in NAFLD: potential therapeutic targets, Biochimica et Biophysica Acta, 1821, 809, 10.1016/j.bbalip.2011.10.016
Thomassen, 1982, Characterization of the stimulatory effect of high-fat diets on peroxisomal beta-oxidation in rat liver, Biochemical Journal, 206, 195, 10.1042/bj2060195
Ye, 2001, Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation, Diabetes, 50, 411, 10.2337/diabetes.50.2.411
Fabbrini, 2010, Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease, Journal of Clinical Endocrinology and Metabolism, 95, 2727, 10.1210/jc.2009-2622
Oosterveer, 2009, Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice, Journal of Biological Chemistry, 284, 34036, 10.1074/jbc.M109.051052
Chen, 2008, Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist, Metabolism, 57, 1516, 10.1016/j.metabol.2008.06.005
Guerre-Millo, 2000, Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity, Journal of Biological Chemistry, 275, 16638, 10.1074/jbc.275.22.16638
Schafer, 2012, AVE8134, a novel potent PPARalpha agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats, Acta pharmacologica Sinica, 33, 82, 10.1038/aps.2011.165
Enger, 1977, The effect of clofibrate on glucose tolerance, insulin secretion, triglycerides and fibrinogen in patients with coronary heart disease, Acta Medica Scandinavica, 201, 563, 10.1111/j.0954-6820.1977.tb15748.x
Ferrari, 1977, Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia, Metabolism, 26, 129, 10.1016/0026-0495(77)90048-8
Ferrari, 1978, Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes, Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 10, 4, 10.1055/s-0028-1093469
Kobayashi, 1988, Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study, Diabetes Care, 11, 495, 10.2337/diacare.11.6.495
Anderlova, 2007, Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes, Physiological Research, 56, 579, 10.33549/physiolres.931058
Belfort, 2010, Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome, Journal of Clinical Endocrinology and Metabolism, 95, 829, 10.1210/jc.2009-1487
Perreault, 2011, Fenofibrate administration does not affect muscle triglyceride concentration or insulin sensitivity in humans, Metabolism, 60, 1107, 10.1016/j.metabol.2010.12.003
Subramanian, 2006, PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans, American Journal of Physiology – Endocrinology and Metabolism, 291, E1365, 10.1152/ajpendo.00230.2006
Motojima, 2003, Fibrates and statins rapidly and synergistically induce pyruvate dehydrogenase kinase 4 mRNA in the liver and muscles of mice, Biological and Pharmaceutical Bulletin, 26, 954, 10.1248/bpb.26.954
Walters, 2010, Urea cycle gene expression is suppressed by PFOA treatment in rats, Toxicology Letters, 197, 46, 10.1016/j.toxlet.2010.04.027
Edvardsson, 2003, Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators, Proteomics, 3, 468, 10.1002/pmic.200390061
Leonard, 2006, Proteomic characterization of the effects of clofibrate on protein expression in rat liver, Proteomics, 6, 1915, 10.1002/pmic.200500251
Makino, 2009, Comprehensive analysis of hepatic gene and protein expression profiles on phenobarbital- or clofibrate-induced hepatic hypertrophy in dogs, Journal of Toxicological Sciences, 34, 647, 10.2131/jts.34.647
Sheikh, 2007, Beyond lipids, pharmacological PPARalpha activation has important effects on amino acid metabolism as studied in the rat, American Journal of Physiology – Endocrinology and Metabolism, 292, E1157, 10.1152/ajpendo.00254.2006
Edgar, 1998, Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway, Toxicology Letters, 98, 13, 10.1016/S0378-4274(98)00042-3
Thulin, 2008, PPARalpha regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes, Toxicology and Applied Pharmacology, 231, 1, 10.1016/j.taap.2008.03.007
Tomkiewicz, 2004, Opposite regulation of the rat and human cytosolic aspartate aminotransferase genes by fibrates, Biochemical Pharmacology, 67, 213, 10.1016/j.bcp.2003.07.018
Keller, 1993, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, Proceedings of the National Academy of Sciences of the United States of America, 90, 2160, 10.1073/pnas.90.6.2160
Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma, Proceedings of the National Academy of Sciences of the United States of America, 94, 4318, 10.1073/pnas.94.9.4318
Krey, 1997, Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Molecular Endocrinology, 11, 779, 10.1210/mend.11.6.0007
Lin, 1999, Ligand selectivity of the peroxisome proliferator-activated receptor alpha, Biochemistry, 38, 185, 10.1021/bi9816094
Murakami, 1999, Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha, Biochemical and Biophysical Research Communications, 260, 609, 10.1006/bbrc.1999.0951
Sanderson, 2008, Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics, PLoS One, 3, e1681, 10.1371/journal.pone.0001681
Oswal, 2013, Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities, Journal of Lipid Research, 54, 2354, 10.1194/jlr.M035436
Fang, 2006, 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha, American Journal of Physiology – Heart and Circulatory Physiology, 290, H55, 10.1152/ajpheart.00427.2005
Fu, 2003, Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha, Nature, 425, 90, 10.1038/nature01921
Muga, 2000, 8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes, Cell Growth & Differentiation, 11, 447
Zomer, 2000, Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha, Journal of Lipid Research, 41, 1801, 10.1016/S0022-2275(20)31973-8
Hostetler, 2005, Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands, Journal of Biological Chemistry, 280, 18667, 10.1074/jbc.M412062200
Sun, 2007, Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism, British Journal of Pharmacology, 152, 734, 10.1038/sj.bjp.0707478
JØrgensen, 2002, Opposing effects of fatty acids and acyl-CoA esters on conformation and cofactor recruitment of peroxisome proliferator-activated receptors, Annals of the New York Academy of Sciences, 967, 431, 10.1111/j.1749-6632.2002.tb04299.x
Elholm, 2001, Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with co-factors, Journal of Biological Chemistry, 276, 21410, 10.1074/jbc.M101073200
Chakravarthy, 2009, Identification of a physiologically relevant endogenous ligand for PPARalpha in liver, Cell, 138, 476, 10.1016/j.cell.2009.05.036
Liu, 2013, A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use, Nature, 502, 550, 10.1038/nature12710
Huang, 2004, Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells, Biochemistry, 43, 2484, 10.1021/bi0352318
Huang, 2002, Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells, Journal of Biological Chemistry, 277, 29139, 10.1074/jbc.M202923200
Hostetler, 2009, L-FABP directly interacts with PPARalpha in cultured primary hepatocytes, Journal of Lipid Research, 50, 1663, 10.1194/jlr.M900058-JLR200
McIntosh, 2009, Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes, Archives of Biochemistry and Biophysics, 485, 160, 10.1016/j.abb.2009.03.004
Wolfrum, 2001, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus, Proceedings of the National Academy of Sciences of the United States of America, 98, 2323, 10.1073/pnas.051619898
Kozawa, 2011, Induction of peroxisomal lipid metabolism in mice fed a high-fat diet, Molecular Medicine Reports, 4, 1157
Patsouris, 2006, Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression, Endocrinology, 147, 1508, 10.1210/en.2005-1132
Sunny, 2010, Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet, American Journal of Physiology – Endocrinology and Metabolism, 298, E1226, 10.1152/ajpendo.00033.2010
Brady, 1989, Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs, Biochemical Journal, 260, 93, 10.1042/bj2600093
Ouali, 2000, Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats, Pediatric Research, 48, 691, 10.1203/00006450-200011000-00023
Duval, 2010, Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice, Diabetes, 59, 3181, 10.2337/db10-0224
Gavrilova, 2003, Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass, Journal of Biological Chemistry, 278, 34268, 10.1074/jbc.M300043200
Inoue, 2005, Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice, Biochemical and Biophysical Research Communications, 336, 215, 10.1016/j.bbrc.2005.08.070
Badman, 2007, Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states, Cell Metabolism, 5, 426, 10.1016/j.cmet.2007.05.002
Garbow, 2011, Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet, American Journal of Physiology – Gastrointestinal and Liver Physiology, 300, G956, 10.1152/ajpgi.00539.2010
Martin, 2007, Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study, Hepatology, 45, 767, 10.1002/hep.21510
Ren, 1997, Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha, Journal of Biological Chemistry, 272, 26827, 10.1074/jbc.272.43.26827
Lu, 2011, Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice, Physiological Genomics, 43, 1307, 10.1152/physiolgenomics.00100.2011
Nilsson, 1986, The effect of high-fat diets on microsomal lauric acid hydroxylation in rat liver, Biochimica et Biophysica Acta, 879, 209, 10.1016/0005-2760(86)90104-9
Yamazaki, 1987, A diet rich in (n-3) fatty acids increases peroxisomal beta-oxidation activity and lowers plasma triacylglycerols without inhibiting glutathione-dependent detoxication activities in the rat liver, Biochimica et Biophysica Acta, 920, 62, 10.1016/0005-2760(87)90311-0
Xu, 1999, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Molecular Cell, 3, 397, 10.1016/S1097-2765(00)80467-0
Jia, 2013, Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid, Biochimica et Biophysica Acta, 1831, 698, 10.1016/j.bbalip.2012.11.012
Jia, 2012, The natural carotenoid astaxanthin, a PPAR-alpha agonist and PPAR-gamma antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes, Molecular Nutrition & Food Research, 56, 878, 10.1002/mnfr.201100798
Jia, 2011, Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism, Bioorganic and Medicinal Chemistry Letters, 21, 5876, 10.1016/j.bmcl.2011.07.095
Rimando, 2005, Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters, Journal of Agricultural and Food Chemistry, 53, 3403, 10.1021/jf0580364
Shimura, 2005, Isohumulones modulate blood lipid status through the activation of PPAR alpha, Biochimica et Biophysica Acta, 1736, 51
Mezei, 2006, Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms, Physiological Genomics, 26, 8, 10.1152/physiolgenomics.00155.2005
Moya-Camarena, 1999, Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha, Journal of Lipid Research, 40, 1426, 10.1016/S0022-2275(20)33384-8
Rakhshandehroo, 2009, Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human, PLoS One, 4, e6796, 10.1371/journal.pone.0006796
Ducheix, 2013, A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARalpha, Biochimie, 95, 556, 10.1016/j.biochi.2012.09.028
Willson, 2000, The PPARs: from orphan receptors to drug discovery, Journal of Medicinal Chemistry, 43, 527, 10.1021/jm990554g
Hoekstra, 2003, Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells, Journal of Biological Chemistry, 278, 25448, 10.1074/jbc.M301189200
Mandard, 2004, Peroxisome proliferator-activated receptor alpha target genes, Cellular and Molecular Life Sciences, 61, 393, 10.1007/s00018-003-3216-3
Rakhshandehroo, 2010, Peroxisome proliferator-activated receptor alpha target genes, PPAR Research, 2010, 10.1155/2010/612089
Lee, 2011, The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism, Nature Medicine, 17, 812, 10.1038/nm.2347
Inagaki, 2007, Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21, Cell Metabolism, 5, 415, 10.1016/j.cmet.2007.05.003
Lundasen, 2007, PPARalpha is a key regulator of hepatic FGF21, Biochemical and Biophysical Research Communications, 360, 437, 10.1016/j.bbrc.2007.06.068
Zandbergen, 2005, The G0/G1 switch gene 2 is a novel PPAR target gene, Biochemical Journal, 392, 313, 10.1042/BJ20050636
Kim, 2014, Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21, Endocrinology, 155, 769, 10.1210/en.2013-1490
Guillaumond, 2010, Kruppel-like factor KLF10 is a link between the circadian clock and metabolism in liver, Molecular and Cellular Biology, 30, 3059, 10.1128/MCB.01141-09
Zhang, 2012, Mouse KLF11 regulates hepatic lipid metabolism, Journal of Hepatology, 58, 763, 10.1016/j.jhep.2012.11.024
Gill, 1988, Negative effect of the transcriptional activator GAL4, Nature, 334, 721, 10.1038/334721a0
McMullen, 2013, A map of the PPARalpha transcription regulatory network for primary human hepatocytes, Chemico-biological Interactions, 209C, 14
van der Meer, 2010, Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis, Nucleic Acids Research, 38, 2839, 10.1093/nar/gkq012
Boergesen, 2012, Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites, Molecular and Cellular Biology, 32, 852, 10.1128/MCB.06175-11
Motojima, 1998, Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner, Journal of Biological Chemistry, 273, 16710, 10.1074/jbc.273.27.16710
Guo, 2006, Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists, BMC Bioinformatics, 7, S18, 10.1186/1471-2105-7-S2-S18
Krammer, 2011, Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells, International Journal of Medical Sciences, 8, 599, 10.7150/ijms.8.599
Aoyama, 1998, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha), Journal of Biological Chemistry, 273, 5678, 10.1074/jbc.273.10.5678
Hsu, 2001, Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells, Journal of Biological Chemistry, 276, 27950, 10.1074/jbc.M100258200
Schoonjans, 1995, Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter, Journal of Biological Chemistry, 270, 19269, 10.1074/jbc.270.33.19269
Dongol, 2007, The acyl-CoA thioesterase I is regulated by PPARalpha and HNF4alpha via a distal response element in the promoter, Journal of Lipid Research, 48, 1781, 10.1194/jlr.M700119-JLR200
Brandes, 1990, Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation, Biochimica et Biophysica Acta, 1034, 53, 10.1016/0304-4165(90)90152-M
Poirier, 2001, Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine, Biochemical Journal, 355, 481, 10.1042/bj3550481
Simon, 1993, Use of transgenic mice to map cis-acting elements in the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage-specific, differentiation-dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus, Journal of Biological Chemistry, 268, 18345, 10.1016/S0021-9258(17)46851-7
Storch, 2009, Structural and functional analysis of fatty acid-binding proteins, Journal of Lipid Research, S126, 10.1194/jlr.R800084-JLR200
Fourcade, 2001, Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha, European Journal of Biochemistry, 268, 3490, 10.1046/j.1432-1327.2001.02249.x
Rampler, 2003, Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy, Molecular Genetics and Metabolism, 80, 398, 10.1016/j.ymgme.2003.09.002
Leclercq, 2008, Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters, Biochimie, 90, 1602, 10.1016/j.biochi.2008.05.022
Hunt, 2002, Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism, Journal of Biological Chemistry, 277, 1128, 10.1074/jbc.M106458200
Bardot, 1993, PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene, Biochemical and Biophysical Research Communications, 192, 37, 10.1006/bbrc.1993.1378
Marcus, 1993, Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression, Proceedings of the National Academy of Sciences of the United States of America, 90, 5723, 10.1073/pnas.90.12.5723
Nicolas-Frances, 2000, The peroxisome proliferator response element (PPRE) present at positions -681/-669 in the rat liver 3-ketoacyl-CoA thiolase B gene functionally interacts differently with PPARalpha and HNF-4, Biochemical and Biophysical Research Communications, 269, 347, 10.1006/bbrc.2000.2249
Shimizu, 2004, Tissue-selective, bidirectional regulation of PEX11 alpha and perilipin genes through a common peroxisome proliferator response element, Molecular and Cellular Biology, 24, 1313, 10.1128/MCB.24.3.1313-1323.2004
Brandt, 1998, Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha, Journal of Biological Chemistry, 273, 23786, 10.1074/jbc.273.37.23786
Mascaro, 1998, Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor, Journal of Biological Chemistry, 273, 8560, 10.1074/jbc.273.15.8560
van Vlies, 2007, PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation, Biochimica et Biophysica Acta, 1767, 1134, 10.1016/j.bbabio.2007.07.001
Wen, 2010, Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron, Biochemical Pharmacology, 79, 768, 10.1016/j.bcp.2009.10.002
Gulick, 1994, The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression, Proceedings of the National Academy of Sciences of the United States of America, 91, 11012, 10.1073/pnas.91.23.11012
Frerman, 1988, Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase, Biochemical Society Transactions, 16, 416, 10.1042/bst0160416
Rodriguez, 1994, Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids, Journal of Biological Chemistry, 269, 18767, 10.1016/S0021-9258(17)32234-2
Kroetz, 1998, Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes, Journal of Biological Chemistry, 273, 31581, 10.1074/jbc.273.47.31581
Muerhoff, 1992, The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid, Journal of Biological Chemistry, 267, 19051, 10.1016/S0021-9258(18)41738-3
Wanders, 2011, Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans, FEBS Journal, 278, 182, 10.1111/j.1742-4658.2010.07947.x
Miller, 1996, Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression, Proceedings of the National Academy of Sciences of the United States of America, 93, 9443, 10.1073/pnas.93.18.9443
Cherkaoui-Malki, 2001, Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis, Gene Expression, 9, 291, 10.3727/000000001783992533
Yu, 2001, Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver, Journal of Biological Chemistry, 276, 42485, 10.1074/jbc.M106480200
Dalen, 2006, PPARalpha activators and fasting induce the expression of adipose differentiation-related protein in liver, Journal of Lipid Research, 47, 931, 10.1194/jlr.M500459-JLR200
Targett-Adams, 2005, A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein, Biochimica et Biophysica Acta, 1728, 95, 10.1016/j.bbaexp.2005.01.017
Dalen, 2004, Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma, Diabetes, 53, 1243, 10.2337/diabetes.53.5.1243
Dalen, 2007, LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues, Biochimica et Biophysica Acta, 1771, 210, 10.1016/j.bbalip.2006.11.011
Wolins, 2006, OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization, Diabetes, 55, 3418, 10.2337/db06-0399
Kadereit, 2008, Evolutionarily conserved gene family important for fat storage, Proceedings of the National Academy of Sciences of the United States of America, 105, 94, 10.1073/pnas.0708579105
Viswakarma, 2007, Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma, Journal of Biological Chemistry, 282, 18613, 10.1074/jbc.M701983200
Matsusue, 2008, Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27, Cell Metabolism, 7, 302, 10.1016/j.cmet.2008.03.003
Costet, 1998, Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, Journal of Biological Chemistry, 273, 29577, 10.1074/jbc.273.45.29577
Stienstra, 2007, Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation, Endocrinology, 148, 2753, 10.1210/en.2007-0014
Liu, 2014, Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARalpha and its relevance to hepatotoxicity, Archives of Toxicology, 88, 983, 10.1007/s00204-013-1188-0
Yamazaki, 2012, Induction of 1-acylglycerophosphocholine acyltransferase genes by fibrates in the liver of rats, Biological and Pharmaceutical Bulletin, 35, 1509, 10.1248/bpb.b12-00243
Kok, 2003, Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse, Gastroenterology, 124, 160, 10.1053/gast.2003.50007
Ghonem, 2013, Peroxisome proliferator-activated receptor alpha activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion, Hepatology, 59, 1030, 10.1002/hep.26894
Hunt, 2000, The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis, Journal of Biological Chemistry, 275, 28947, 10.1074/jbc.M002782200
Chinetti, 2001, PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway, Nature Medicine, 7, 53, 10.1038/83348
Chinetti, 2000, CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors, Circulation, 101, 2411, 10.1161/01.CIR.101.20.2411
Lopez, 2006, Activation of the rat scavenger receptor class B type I gene by PPARalpha, Molecular and Cellular Endocrinology, 251, 67, 10.1016/j.mce.2006.02.011
Mardones, 2003, Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice, Journal of Biological Chemistry, 278, 7884, 10.1074/jbc.M211627200
Bertolotti, 1995, Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7 alpha-hydroxylation in humans, Arteriosclerosis Thrombosis and Vascular Biology, 15, 1064, 10.1161/01.ATV.15.8.1064
Post, 2001, Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression, Arteriosclerosis Thrombosis and Vascular Biology, 21, 1840, 10.1161/hq1101.098228
Stahlberg, 1989, Effects of treatment with clofibrate, bezafibrate, and ciprofibrate on the metabolism of cholesterol in rat liver microsomes, Journal of Lipid Research, 30, 953, 10.1016/S0022-2275(20)38297-3
Stahlberg, 1995, Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase, Hepatology, 21, 1025
Gbaguidi, 2004, The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver X receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer, Nucleic Acids Research, 32, 1113, 10.1093/nar/gkh260
Marrapodi, 2000, Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription, Journal of Lipid Research, 41, 514, 10.1016/S0022-2275(20)32398-1
Li, 2012, Metabolomics reveals an essential role for peroxisome proliferator-activated receptor alpha in bile acid homeostasis, Journal of Lipid Research, 53, 1625, 10.1194/jlr.M027433
Li, 2009, Regulation of bile acid and cholesterol metabolism by PPARs, PPAR Research, 2009, 501739, 10.1155/2009/501739
Szatmari, 2006, PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells, Journal of Experimental Medicine, 203, 2351, 10.1084/jem.20060141
Sun, 2008, Identification and characterization of a novel mouse peroxisome proliferator-activated receptor alpha-regulated and starvation-induced gene, Ppsig, International Journal of Biochemistry and Cell Biology, 40, 1775, 10.1016/j.biocel.2008.01.006
Jitrapakdee, 2005, The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro, Journal of Biological Chemistry, 280, 27466, 10.1074/jbc.M503836200
White, 2011, Differential regulation of bovine pyruvate carboxylase promoters by fatty acids and peroxisome proliferator-activated receptor-alpha agonist, Journal of Dairy Science, 94, 3428, 10.3168/jds.2010-3960
Wu, 2001, Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha, Biochemical and Biophysical Research Communications, 287, 391, 10.1006/bbrc.2001.5608
Fisher, 2011, Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo, Endocrinology, 152, 2996, 10.1210/en.2011-0281
Potthoff, 2009, FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response, Proceedings of the National Academy of Sciences of the United States of America, 106, 10853, 10.1073/pnas.0904187106
Jonker, 2012, A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis, Nature, 485, 391, 10.1038/nature10998
Kersten, 2000, Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene, Journal of Biological Chemistry, 275, 28488, 10.1074/jbc.M004029200
Rakhshandehroo, 2012, Plasma mannose-binding lectin is stimulated by PPARalpha in humans, American Journal of Physiology – Endocrinology and Metabolism, 302, E595, 10.1152/ajpendo.00299.2011
Mattijssen, 2012, Regulation of triglyceride metabolism by angiopoietin-like proteins, Biochimica et Biophysica Acta, 1821, 782, 10.1016/j.bbalip.2011.10.010
Tachibana, 2013, Human mannose-binding lectin 2 is directly regulated by peroxisome proliferator-activated receptors via a peroxisome proliferator responsive element, Journal of Biochemistry, 154, 265, 10.1093/jb/mvt050
Rommelaere, 2013, PPARalpha regulates the production of serum vanin-1 by liver, FEBS Letters, 587, 3742, 10.1016/j.febslet.2013.09.046
van Diepen, J.A., Jansen, P.A., Ballak, D.B., Hijmans, A., Hooiveld, G.J., Mensink, R.P., et al. PPAR-alpha dependent regulation of Vanin-1 mediates hepatic lipid metabolism. Journal of Hepatology. In press.
Blaauboer, 1990, The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes, Biochemical Pharmacology, 40, 521, 10.1016/0006-2952(90)90551-U
Cattley, 1998, Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?, Regulatory Toxicology and Pharmacology: RTP, 27, 47, 10.1006/rtph.1997.1163
Lambe, 1999, Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter, Toxicology Letters, 110, 119, 10.1016/S0378-4274(99)00151-4
Vu-Dac, 1995, Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor, Journal of Clinical Investigation, 96, 741, 10.1172/JCI118118
Prieur, 2003, The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element, Journal of Biological Chemistry, 278, 25468, 10.1074/jbc.M301302200
Schultze, 2005, Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio, Journal of Lipid Research, 46, 1591, 10.1194/jlr.C500010-JLR200